Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

August 2, 2020

Study Completion Date

September 28, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

Vadadustat

2 x 150 mg oral tablets

DRUG

Sevelamer carbonate

2 x 800 mg oral tablets

DRUG

Calcium acetate

2 x 667 mg oral gelcaps

DRUG

Auryxia®

2 x 1 gram tablets (210 mg ferric iron equivalent to 1000 mg ferric citrate)

Trial Locations (1)

Research Site, Québec